Patents by Inventor Katherine Gordon

Katherine Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for searching a schema to identify and visualize corresponding data
    Patent number: 11494454
    Abstract: Systems and methods are provided for searching a schema to identify and visualize corresponding data. The system may be configured to receive a search query and search the schema for columns that correspond to one another. Individual ones of the corresponding columns may have different labels or different data types. Results for the search query may be determined. The results may include a first set of columns that satisfy the search query including a first column and a second column that correspond to each other but have one or more different labels or different data types. The system may be configured to generate a graphical representation of a data distribution for the first column responsive to receiving a selection of the first column.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: November 8, 2022
    Assignee: Palantir Technologies Inc.
    Inventors: Katherine Gordon, Aaron Stromberg, Jacquelyn Sanchez, Katherine Karg, Nghia Nguyen
  • Transgenic animals secreting desired proteins into milk
    Patent number: 7939317
    Abstract: A DNA sequence containing a gene encoding a protein, the gene being under the transcriptional control in the DNA sequence of a mammalian milk protein promoter which does not naturally control the transcription of the gene, such DNA sequence including DNA enabling secretion of the protein.
    Type: Grant
    Filed: February 20, 1992
    Date of Patent: May 10, 2011
    Assignee: Genzyme Corporation
    Inventors: Katherine Gordon, Suzanne Groet
  • Transgenic animals secreting proteins into milk
    Patent number: 7045676
    Abstract: A DNA sequence containing a gene encoding a protein, the gene being under the transcriptional control in the DNA sequence of a mammalian milk protein promoter which does not naturally control the transcription of the gene, such DNA sequence including DNA enabling secretion of the protein.
    Type: Grant
    Filed: August 31, 1992
    Date of Patent: May 16, 2006
    Assignee: GTC Biotherapeutics, Inc.
    Inventors: Katherine Gordon, Suzanne Groet
  • Transgenic animals secreting desired proteins into milk
    Patent number: 6727405
    Abstract: A DNA sequence containing a gene encoding a protein, the gene being under the transcriptional control in the DNA sequence of a mammalian milk protein promoter which does not naturally control the transcription of the gene, such DNA sequence including DNA enabling secretion of the protein.
    Type: Grant
    Filed: May 19, 1994
    Date of Patent: April 27, 2004
    Assignee: Genzyme Corporation
    Inventors: Katherine Gordon, Suzanne Groet, Lothar Hennighausen, Heiner Westphal
  • Treatment of opthalmic diseases
    Publication number: 20030105167
    Abstract: The present invention relates to a method of using protective compounds for the prevention or treatment of ophthalmic diseases, disorders or injuries in a subject. The method comprises the step of administering a predetermined polycyclic phenolic compound to a subject in need thereof. The polycyclic phenolic compound is selected from those having at least one terminal phenolic group and at least one other cyclic group.
    Type: Application
    Filed: December 5, 2002
    Publication date: June 5, 2003
    Inventors: James Alan Dykens, Katherine Gordon
  • Neuroprotective effects of polycyclic phenolic compounds
    Patent number: 6197833
    Abstract: A method is provided for conferring neuroprotection on a population of cells in a subject, the method including providing a polycyclic compound having a terminal phenolic group in a structure containing at least a second ring, the compound having a molecular weight of less than 1000 Daltons, the compound not including estrogen compounds including estrogen agonists. The compound may be administered in an effective dose to the population of cells so as to confer neuroprotection. Methods are further provided for treating a neurodegenerative disease in a subject that include providing an effective dose of a formulation containing the compound and administering the dose to the subject.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: March 6, 2001
    Assignees: Apollo Biopharmaceutics, Inc., University of Florida Research Foundation, Inc.
    Inventors: James W Simpkins, Katherine Gordon, Pattie S. Green
  • Neuroprotective effects of polycyclic phenolic compounds
    Patent number: 5859001
    Abstract: This application relates to the use of non-estrogen compounds having a terminal phenol group in a four-ring cyclopentanophenanthrene compound structure for conferring neuroprotection to cells and for the treatment of neurodegenerative diseases.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: January 12, 1999
    Assignees: University of Florida Research Foundation, Inc., Apollo Genetics
    Inventors: James W Simpkins, Katherine Gordon, Pattie S. Green